Category Releases Selux Diagnostics Announces Appointment of John Wilson as Chief Commercial Officer November 16, 2021 Read More Category Releases Selux Diagnostics Awarded $2.8 Million Grant from NIH for Commercialization of its NGP Platform October 19, 2021 Read More Category Releases Selux Diagnostics Earns FDA Breakthrough Device Designation for Next Generation ‘Phenotyping’ (NGP) Platform for Positive Blood Culture and Sterile Body Fluid Samples September 28, 2021 Read More Category Releases Selux Diagnostics Receives Additional $14.6 Million in BARDA Funding After Successfully Completing First Clinical Trial June 9, 2021 Read More Category Releases Selux Diagnostics Receives $9.6 Million in Additional Funding, Speeding Development of Breakthrough Rapid AST Platform April 27, 2020 Read More Category Releases ECCMID 2020 Alert: Selux Diagnostics Hosting Integrated Symposium at 30th European Congress of Clinical Microbiology & Infectious Diseases February 18, 2020 Read More Category Releases Selux Diagnostics Beats Key Contract Milestone, Receives $11.4M in Additional Funding October 2, 2019 Read More Category Releases Selux Diagnostics Selected to lead IDWeek 2019 Panel Presentation, Poster Session September 10, 2019 Read More Category Releases Selux Diagnostics Announces Selection of Three Abstracts for Poster Sessions at ASM Microbe Conference June 10, 2019 Read More Category Releases Selux Diagnostics Announces Milestone-Based Contract for U.S. HHS/BARDA Research Funding September 28, 2018 Read More
